Orchids Paper Products Gets Lender Consent

Orchids Paper Products Gets Lender Consent

Orchids Paper Products said it and its lenders have agreed to amend their credit agreement to, among other things, strike the fixed charge coverage for the period ended June 30 and waive the cash reserve requirement, the company said late Wednesday. The company said it is currently exploring refinancing of some or all of its current outstanding indebtedness to increase financial flexibility and create greater available liquidity. “We continue to […]

Read More ˃
GlaxoSmithKline Starts Phase III Study

GlaxoSmithKline Starts Phase III Study

GlaxoSmithKline said early Tuesday it commenced a phase III study evaluating mepolizumab in patients with severe bilateral nasal polyps, a chronic inflammatory disease of the nasal passage linings or sinuses. The drug maker said the study will evaluate the safety and efficacy of subcutaneous mepolizumab versus placebo in 400 adult patients with recurrent severe bilateral nasal polyps. The study is slated for completion in 2019. Separately, GlaxoSmithKline said it received […]

Read More ˃
Celsion to Sell Shares in Registered Direct Offering

Celsion to Sell Shares in Registered Direct Offering

Celsion said Monday morning it agreed with several institutional investors to sell an aggregate of approximately 2 million shares of common stock, or pre-funded warrants in lieu thereof, in a registered direct offering at $2.75 per share. Shares were trading more than 22% lower. Additionally, the investors will receive, for each share of common stock or pre-funded warrant purchased in the registered direct offering, a series AAA warrant to purchase […]

Read More ˃
Hilton Worldwide PT Raised by RBC

Hilton Worldwide PT Raised by RBC

Hilton Worldwide Holdings received a price-target increase Monday from RBC Capital Markets, which cited a combination of multiple expansion and a higher forecast for earnings before interest, taxes, depreciation and amortization. The new price target from RBC is $71 per share, up from $62. In comparison, the stock closed Friday’s session at $64.75, up 15% from three months ago. RBC kept its investment rating on the stock at outperform.”We believe […]

Read More ˃
Hilton Prices Shares in Secondary Offering

Hilton Prices Shares in Secondary Offering

Hilton Worldwide Holdings, a global hospitality company, priced a secondary offering of 15 million shares of Hilton common stock by certain selling stockholders affiliated with The Blackstone Group. The offering is expected to close Tuesday, the company said in a press release Thursday. Hilton said it is not offering any shares of common stock in the offering and will not get any proceeds from the sale of shares in this […]

Read More ˃
Eleven Biotherapeutics Shares Gain

Eleven Biotherapeutics Shares Gain

Eleven Biotherapeutics shares rose 6% on Tuesday after the company said has struck a deal to develop its Vicinium in combination with AstraZeneca’s (AZN) Imfinzi for the treatment of non-muscle invasive bladder cancer. Under the agreement, the National Cancer Institute will conduct a phase 1 clinical trial to evaluate the safety, efficacy, and biological correlates of the drug combination therapeutic strategy. “While we remain internally focused on advancing our phase […]

Read More ˃
Acxiom Forms Marketing-Focused Partnerships

Acxiom Forms Marketing-Focused Partnerships

Acxiom said early Wednesday it was selected by The Michaels Companies’ (MIK) Michaels Stores to provide its integrated, data-driven marketing solutions to enhance customer experience and optimize marketing investments. “Acxiom connects our marketing and advertising ecosystem at the data layer. This will help us improve our customer engagement, increase the relevance of our customer communication, and enable us to more fully measure the effectiveness of our marketing programs,” said Steve […]

Read More ˃